DrugDashboards

Market view

piperacillin sodium and tazobactam sodium · Injection, Solution

3 marketed package NDCs · 1 active manufacturer

Most dispensed: 3 g; .375 g · Injection, Powder, Lyophilized, For Solution · #10 vials/box / 1 injection, powder, lyophilized, for solution in 1 vial · 3 g/15mL; .375 g/15mL · Injection, Powder, Lyophilized, For Solution · #10 vial, single-doses/carton / 15 ml in 1 vial, single-dose · 3 g/15mL; .375 g/15mL · Injection, Powder, For Solution · #10 vial, single-doses/carton / 15 ml in 1 vial, single-dose · 36 g/180mL; 4.5 g/180mL · Injection, Powder, For Solution · #1 bottle/carton / 180 ml in 1 bottle

The short version

Only one company currently supplies this market — there is no backup if it stumbles. Historically, drugs in this position went on to a new shortage within 90 days about 0.5% of the time — roughly 4× the typical drug (0.1%).

Same drug class

Other molecules FDA puts in beta Lactamase Inhibitor, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Piperacillin sodium and tazobactam sodium in shortage right now?
No. FDA does not currently list Piperacillin sodium and tazobactam sodium in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Piperacillin sodium and tazobactam sodium?
7 companies have marketed Piperacillin sodium and tazobactam sodium in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.